8-K
filed May 19, 2026, 4:18 PM ET
ticker BHC
CIK 0000885590
other material
confidence high
sentiment neutral
materiality 0.15
Bausch Health elects Eiry W. Roberts as new director; say-on-pay passes at annual meeting
Bausch Health Companies Inc.
- Eiry W. Roberts elected to board with 196,972,752 votes for, 2,585,679 withheld; broker non-votes 79,859,606.
- All other incumbent directors re-elected; vote tallies range from 183.9M to 196.8M for.
- Say-on-pay advisory vote passed: 189,432,400 for, 9,588,417 against, 537,614 abstain.
- PricewaterhouseCoopers LLP appointed as auditor for 2027 fiscal year with 276,774,936 for, 2,643,100 withheld.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bausch Health Companies Inc. shareholders approved Election of Directors at the 2026-05-19 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
The shareholders elected the following individuals to the Company’s Board of Directors, including Eiry W. Roberts, M.D., who was elected as a new director, to serve until the close of the Company’s 2027 Annual Meeting of Shareholders, until their successors are duly elected or appointed, or until such director’s earlier resignation or removal:
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bausch Health Companies Inc. shareholders approved Appointment of the Independent Registered Public Accounting Firm at the 2026-05-19 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
The shareholders appointed PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2027 Annual Meeting of Shareholders and authorized the Company’s Board of Directors to fix the auditors’ remuneration.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Bausch Health Companies Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-05-19 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-19
Exact text from the filing
The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.